Breaking News, Collaborations & Alliances

Catalent Divests Blow-Fill-Seal Sterile CDMO Business

SK Capital makes the acquisition; new independent company to be formed.

By: Contract Pharma

Contract Pharma Staff

SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquired the Blow-Fill-Seal (BFS) sterile contract development and manufacturing business from Catalent Pharma Solutions. The acquisition of the BFS business, which will operate as a new independent company, is expected to close in April of 2021.   The business is a leading BFS sterile contract development and manufacturing organization (CDMO) that operates out of a singl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters